Free Trial
→ The Robotics Revolution has arrived … and one $7 stock could take off as a result. (From Weiss Ratings) (Ad) Free ARQT Stock Alerts

Arcutis Biotherapeutics (ARQT) SEC Filings & 10K Form

Arcutis Biotherapeutics logo
$15.40 -0.50 (-3.14%)
Closing price 07/15/2025 04:00 PM Eastern
Extended Trading
$15.29 -0.11 (-0.71%)
As of 07/15/2025 07:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Arcutis Biotherapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
07/14/2025
3:02 PM		Arcutis Biotherapeutics (Issuer)
Burnett Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/14/2025
11:27 AM		Arcutis Biotherapeutics (Subject)
Burnett Patrick (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/10/2025
2:55 PM		Arcutis Biotherapeutics (Subject)
Burnett Patrick (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/01/2025
9:12 AM		Arcutis Biotherapeutics (Subject)
Welgus Howard G. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/20/2025
3:32 PM		Arcutis Biotherapeutics (Issuer)
Welgus Howard G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2025
1:09 PM		Arcutis Biotherapeutics (Subject)
Welgus Howard G. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/17/2025
4:45 PM		Arcutis Biotherapeutics (Issuer)
Heron Patrick J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2025
3:52 PM		Arcutis Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/16/2025
7:16 PM		Arcutis Biotherapeutics (Issuer)
CHAUDHURI BHASKAR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025
7:17 PM		Arcutis Biotherapeutics (Issuer)
Gilbert Halley E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025
7:17 PM		Arcutis Biotherapeutics (Issuer)
Krishnamohan Neha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025
7:17 PM		Arcutis Biotherapeutics (Issuer)
Curran Terrie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025
7:17 PM		Arcutis Biotherapeutics (Issuer)
Leonard Keith R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025
7:17 PM		Arcutis Biotherapeutics (Issuer)
Heron Patrick J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025
7:17 PM		Arcutis Biotherapeutics (Issuer)
Welgus Howard G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025
7:18 PM		Arcutis Biotherapeutics (Issuer)
LIN SUE-JEAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
3:53 PM		Arcutis Biotherapeutics (Issuer)
Watanabe Todd Franklin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2025
7:44 AM		Arcutis Biotherapeutics (Issuer)
Heron Patrick J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2025
7:25 PM		Arcutis Biotherapeutics (Issuer)
Matsuda Masaru (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2025
3:37 PM		Arcutis Biotherapeutics (Issuer)
Edwards Larry Todd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2025
4:41 PM		Arcutis Biotherapeutics (Subject)
PRUDENTIAL FINANCIAL INC (Filed by)
PRUDENTIAL FINANCIAL INC (Filed by)
Form SCHEDULE 13G/A
05/09/2025
6:45 PM		Arcutis Biotherapeutics (Issuer)
Burnett Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2025
4:59 PM		Arcutis Biotherapeutics (Subject)
JENNISON ASSOCIATES LLC (Filed by)
Form SCHEDULE 13G/A
05/08/2025
1:54 PM		Arcutis Biotherapeutics (Subject)
Burnett Patrick (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/07/2025
6:27 PM		Arcutis Biotherapeutics (Issuer)
Vairavan Latha (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/07/2025
6:29 PM		Arcutis Biotherapeutics (Issuer)
Vairavan Latha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2025
3:49 PM		Arcutis Biotherapeutics (Issuer)
Welgus Howard G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2025
3:20 PM		Arcutis Biotherapeutics (Subject)
Matsuda Masaru (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/02/2025
3:20 PM		Arcutis Biotherapeutics (Subject)
Burnett Patrick (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/10/2025
4:15 PM		Arcutis Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/03/2025
3:21 PM		Arcutis Biotherapeutics (Issuer)
Topper David Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2025
3:21 PM		Arcutis Biotherapeutics (Issuer)
Welgus Howard G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2025
3:41 PM		Arcutis Biotherapeutics (Issuer)
Watanabe Todd Franklin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
3:20 PM		Arcutis Biotherapeutics (Subject)
Watanabe Todd Franklin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/20/2025
5:27 PM		Arcutis Biotherapeutics (Issuer)
Watanabe Todd Franklin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2025
3:19 PM		Arcutis Biotherapeutics (Subject)
Burnett Patrick (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/13/2025
4:10 PM		Arcutis Biotherapeutics (Subject)
Burnett Patrick (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2025
6:43 PM		Arcutis Biotherapeutics (Issuer)
Matsuda Masaru (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:43 PM		Arcutis Biotherapeutics (Issuer)
Edwards Larry Todd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:43 PM		Arcutis Biotherapeutics (Issuer)
Welgus Howard G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:43 PM		Arcutis Biotherapeutics (Issuer)
Topper David Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
[ATTENTION] This Crypto Rocket Is About Launch… (Ad)

Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to two crypto experts, that moment is here. Their Crypto Code Workshop shows how to get positioned before altcoins take off, ride the wave, and lock in gains — with a free $10 Bitcoin bonus just for attending.

Join The Crypto Code Workshop + get $10 in Bitcoin for attending
03/04/2025
6:43 PM		Arcutis Biotherapeutics (Issuer)
Watanabe Todd Franklin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:44 PM		Arcutis Biotherapeutics (Issuer)
Burnett Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
3:46 PM		Arcutis Biotherapeutics (Subject)
Watanabe Todd Franklin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2025
3:47 PM		Arcutis Biotherapeutics (Subject)
Burnett Patrick (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
4:39 PM		Arcutis Biotherapeutics (Subject)
Watanabe Todd Franklin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
4:36 PM		Arcutis Biotherapeutics (Subject)
Burnett Patrick (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
4:38 PM		Arcutis Biotherapeutics (Subject)
Matsuda Masaru (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
3:50 PM		Arcutis Biotherapeutics (Subject)
Welgus Howard G. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/25/2025
3:13 PM		Arcutis Biotherapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/04/2025
7:00 PM		Arcutis Biotherapeutics (Issuer)
Edwards Larry Todd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
7:00 PM		Arcutis Biotherapeutics (Issuer)
Burnett Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
7:00 PM		Arcutis Biotherapeutics (Issuer)
Welgus Howard G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
7:01 PM		Arcutis Biotherapeutics (Issuer)
Watanabe Todd Franklin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
7:01 PM		Arcutis Biotherapeutics (Issuer)
Matsuda Masaru (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
5:03 PM		Arcutis Biotherapeutics (Subject)
Matsuda Masaru (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/03/2025
5:04 PM		Arcutis Biotherapeutics (Subject)
Watanabe Todd Franklin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/03/2025
5:01 PM		Arcutis Biotherapeutics (Subject)
Burnett Patrick (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/03/2025
5:02 PM		Arcutis Biotherapeutics (Subject)
Edwards Larry Todd (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/03/2025
4:10 PM		Arcutis Biotherapeutics (Subject)
Welgus Howard G. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/13/2025
6:33 AM		Arcutis Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2025
4:26 PM		Arcutis Biotherapeutics (Subject)
Welgus Howard G. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/31/2024
5:13 PM		Arcutis Biotherapeutics (Issuer)
Burnett Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:19 PM		Arcutis Biotherapeutics (Subject)
Burnett Patrick (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/23/2024
6:22 PM		Arcutis Biotherapeutics (Issuer)
Watanabe Todd Franklin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
4:02 PM		Arcutis Biotherapeutics (Subject)
Watanabe Todd Franklin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/02/2024
3:25 PM		Arcutis Biotherapeutics (Subject)
Welgus Howard G. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/26/2024
3:21 PM		Arcutis Biotherapeutics (Issuer)
Burnett Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2024
6:52 PM		Arcutis Biotherapeutics (Issuer)
Matsuda Masaru (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2024
3:25 PM		Arcutis Biotherapeutics (Subject)
Matsuda Masaru (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/18/2024
6:04 PM		Arcutis Biotherapeutics (Issuer)
Burnett Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2024
3:31 PM		Arcutis Biotherapeutics (Subject)
Burnett Patrick (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2024
6:50 PM		Arcutis Biotherapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SC 13G/A
11/13/2024
5:45 PM		Arcutis Biotherapeutics (Issuer)
Curran Terrie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
3:30 PM		Arcutis Biotherapeutics (Subject)
Rubric Capital Management LP (Filed by)
Form SC 13G/A
11/12/2024
10:34 AM		Arcutis Biotherapeutics (Subject)
Curran Terrie (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/06/2024
3:07 PM		Arcutis Biotherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/04/2024
3:41 PM		Arcutis Biotherapeutics (Subject)
Watanabe Todd Franklin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/01/2024
1:51 PM		Arcutis Biotherapeutics (Subject)
Welgus Howard G. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/22/2024
2:24 PM		Arcutis Biotherapeutics (Subject)
BlackRock, Inc. (Filed by)
Form SC 13G/A
10/03/2024
3:55 PM		Arcutis Biotherapeutics (Issuer)
Edwards Larry Todd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
3:55 PM		Arcutis Biotherapeutics (Issuer)
Welgus Howard G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
2:32 PM		Arcutis Biotherapeutics (Subject)
Welgus Howard G. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/25/2024
8:42 PM		Arcutis Biotherapeutics (Issuer)
Topper David Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/24/2024
2:51 PM		Arcutis Biotherapeutics (Subject)
Topper David Joseph (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/05/2024
4:56 PM		Arcutis Biotherapeutics (Issuer)
Welgus Howard G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
12:37 PM		Arcutis Biotherapeutics (Subject)
Welgus Howard G. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/21/2024
3:39 PM		Arcutis Biotherapeutics (Issuer)
Burnett Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
4:43 PM		Arcutis Biotherapeutics (Subject)
Burnett Patrick (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/01/2024
3:45 PM		Arcutis Biotherapeutics (Subject)
Welgus Howard G. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/24/2024
3:10 PM		Arcutis Biotherapeutics (Filer)
Form 10-Q/A
Which Gold Miner Trades at 30% of NAV? The One Buffett Wants (Ad)

Some of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. With gold at record highs and Bridgewater now buying in, one analyst believes Buffett’s next move could hit by August 15th. He’s identified the gold miner that fits Buffett’s profile — plus four smaller plays with even more upside.

Get the name of Buffett’s likely gold target here
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:ARQT) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...
American Alternative | Sponsored
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsored
Why Elon is funding the “Quantum Power Grid”
Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...
True Market Insiders | Sponsored
Which Gold Miner Trades at 30% of NAV? The One Buffett Wants
Some of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...
Golden Portfolio | Sponsored
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsored
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Paradigm Press | Sponsored
Special gold investment soars 2,300% ... 5,090% ... 9,850%
In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...
Weiss Ratings | Sponsored
Post-Halving = Profit Season (Here’s How to Win It)
It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...
Crypto Swap Profits | Sponsored